Statistical analyses
PD
Pharmacodynamic (PD) analyses were conducted using the Completer Population, defined as participants who completed all treatment periods and had at least one response on the VAS for Drug Liking within 2 h of peak plasma concentrations (TThe primary PD endpoint, Drug Liking VAS EPharmacodynamic endpoints (EPharmacokinetic (PK) parameters (peak plasma concentration [C